Intraperitoneal (IP) Cisplatin Given With Paclitaxel to Treat Epithelial Ovarian Cancer

NCT00889733 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped Poor recruitment

Conditions

Epithelial Ovarian Cancer

Interventions

DRUG: Intraperitoneal (IP) Cisplatin

Sponsor

University Health Network, Toronto

Collaborators

[object Object]